<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
83703-048-05
</NDCCode>
<PackageDescription>
5 SYRINGE in 1 CARTON (83703-048-05) / .5 mL in 1 SYRINGE (83703-048-01)
</PackageDescription>
<NDC11Code>
83703-0048-05
</NDC11Code>
<ProductNDC>
83703-048
</ProductNDC>
<ProductTypeName>
VACCINE
</ProductTypeName>
<ProprietaryName>
Heplisav-b
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Hepatitis B Vaccine (recombinant) Adjuvanted
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION
</DosageFormName>
<RouteName>
INTRAMUSCULAR
</RouteName>
<StartMarketingDate>
20180101
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
BLA
</MarketingCategoryName>
<ApplicationNumber>
BLA125428
</ApplicationNumber>
<LabelerName>
Bamboo US BidCo LLC
</LabelerName>
<SubstanceName>
HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN
</SubstanceName>
<StrengthNumber>
20
</StrengthNumber>
<StrengthUnit>
ug/.5mL
</StrengthUnit>
<Pharm_Classes>
Actively Acquired Immunity [PE], Hepatitis B Vaccines [CS], Inactivated Hepatitis B Virus Vaccine [EPC], Vaccines, Inactivated [CS]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2025-07-16
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20180101
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>